# Meningococcal Infection; Healthy Volunteers FDA approvals and PDUFA dates

Canonical: https://sec-api.dev/indications/meningococcal-infection-healthy-volunteers

> 2 upcoming FDA catalysts in meningococcal Infection; Healthy Volunteers: menquadfi® (meningococcal polysaccharide [serogroups a, c, w, and y] tetanus toxoid conjugate vaccine) (sanofi pasteur inc., swiftwater, pa, usa, SNY) on Mar to Jun 2028 (topline data readout); menquadfi® (meningococcal polysaccharide [serogroups a, c, w, and y] tetanus toxoid conjugate vaccine) (sanofi pasteur inc., swiftwater, pa, usa, SNY) on March 2028 (primary completion).

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day, quarter only, month only.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| May 1, 2026 | [Menacyw conjugate vaccine primary completion](https://sec-api.dev/pdufa/menacyw-conjugate-vaccine) | SNY | Meningococcal Infection; Healthy Volunteers | completed | "NCT07135986 (Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China): Overall Status COMPLETED; Phase PHASE3; Primary Completion 2026-05-01 (ACTUAL); Lead Sponsor Sanofi." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT07135986)) |
| Mar to Jun 2028 | [Menquadfi® (meningococcal polysaccharide [serogroups a, c, w, and y] tetanus toxoid conjugate vaccine) (sanofi pasteur inc., swiftwater, pa, usa) topline data readout](https://sec-api.dev/pdufa/menquadfi-meningococcal-polysaccharide-serogroups-a-c-w-and-y-tetanus-toxoid-con) | SNY | Meningococcal Infection; Healthy Volunteers | scheduled | "NCT07710872 (Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in China): Overall Status RECRUITING; Phase PHASE3; Primary Completion 2028-03-13 (ESTIMATED); Lead Sponsor Sanofi." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT07710872)) |
| March 2028 | [Menquadfi® (meningococcal polysaccharide [serogroups a, c, w, and y] tetanus toxoid conjugate vaccine) (sanofi pasteur inc., swiftwater, pa, usa) primary completion](https://sec-api.dev/pdufa/menquadfi-meningococcal-polysaccharide-serogroups-a-c-w-and-y-tetanus-toxoid-con) | SNY | Meningococcal Infection; Healthy Volunteers | scheduled | "NCT07710872 (Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in China): Overall Status RECRUITING; Phase PHASE3; Primary Completion 2028-03-13 (ESTIMATED); Lead Sponsor Sanofi." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT07710872)) |

## Drugs

- [Menacyw conjugate vaccine](https://sec-api.dev/pdufa/menacyw-conjugate-vaccine) (SNY)
- [Menquadfi® (meningococcal polysaccharide [serogroups a, c, w, and y] tetanus toxoid conjugate vaccine) (sanofi pasteur inc., swiftwater, pa, usa)](https://sec-api.dev/pdufa/menquadfi-meningococcal-polysaccharide-serogroups-a-c-w-and-y-tetanus-toxoid-con) (SNY)

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/indications/meningococcal-infection-healthy-volunteers.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "Meningococcal Infection; Healthy Volunteers FDA approvals and PDUFA dates." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/indications/meningococcal-infection-healthy-volunteers

```bibtex
@misc{secapidev_indications_meningococcal_infection_healthy_volunteers_20261116,
  title        = {Meningococcal Infection; Healthy Volunteers FDA approvals and PDUFA dates},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/indications/meningococcal-infection-healthy-volunteers}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_indications_meningococcal_infection_healthy_volunteers_20261116","title":"Meningococcal Infection; Healthy Volunteers FDA approvals and PDUFA dates","publisher":"sec-api.dev","URL":"https://sec-api.dev/indications/meningococcal-infection-healthy-volunteers","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
